TCM
RVMD icon

Tang Capital Management’s Revolution Medicines RVMD Stock Holding History

Tang Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,640
Closed -$1.25M – 68
2025
Q4 		$1.25M Sell
15,640
-84,360
-84% -$5.53M 0.06% 69
2025
Q3 		$4.67M Hold
100,000
– – 0.18% 97
2025
Q2 		$3.68M Hold
100,000
– – 0.19% 97
2025
Q1 		$3.54M Hold
100,000
– – 0.2% 92
2024
Q4 		$4.37M Buy
+100,000
New +$5.05M 0.29% 79
2024
Q1 		– Sell
-679,630
Closed -$19.5M – 124
2023
Q4 		$19.5M Buy
+679,630
New +$16.3M 1.8% 14

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Tang Capital Management's RVMD Position: Q1 2026 in Review

Tang Capital Management sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 15,640 shares — an estimated $1.25M sold.

Tang Capital Management first reported a position in RVMD in Q4 2023 and held it in 6 quarters. The position peaked at $19.5M in Q4 2023. 514 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Tang Capital Management reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • Tang Capital Management sold 15,640 Revolution Medicines shares in Q1 2026, an estimated $1.25M.
  • Tang Capital Management first reported a position in Revolution Medicines in Q4 2023 and held it in 6 quarters.
  • Tang Capital Management's Revolution Medicines position peaked at $19.5M in Q4 2023.
  • 514 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.